Design and operation of a continuous integrated monoclonal antibody production process
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The realization of an end‐to‐end integrated continuous lab‐scale process for monoclonal antibody manufacturing is described. For this, a continuous cultivation with filter‐based cell‐retention, a continuous two column capture process, a virus inactivation step, a semi‐continuous polishing step (twin‐column MCSGP), and a batch‐wise flow‐through polishing step were integrated and operated together. In each unit, the implementation of internal recycle loops allows to improve the performance: (a) in the bioreactor, to simultaneously increase the cell density and volumetric productivity, (b) in the capture process, to achieve improved capacity utilization at high productivity and yield, and (c) in the MCSGP process, to overcome the purity‐yield trade‐off of classical batch‐wise bind‐elute polishing steps. Furthermore, the design principles, which allow the direct connection of these steps, some at steady state and some at cyclic steady state, as well as straight‐through processing, are discussed. The setup was operated for the continuous production of a commercial monoclonal antibody, resulting in stable operation and uniform product quality over the 17 cycles of the end‐to‐end integration. The steady‐state operation was fully characterized by analyzing at the outlet of each unit at steady state the product titer as well as the process (HCP, DNA, leached Protein A) and product (aggregates, fragments) related impurities. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:1303–1313, 2017
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Karst, D. J., Serra, E., Villiger, T. K., Soos, M., & Morbidelli, M. (2016) · Biochemical Engineering Journal · doi:10.1016/j.bej.2016.02.003 · Cited by 151 · cited 9×
“The integration of the continuous capture process to the perfusion bioreactor is described in detail by Karst et al.18 A small surge tank, with a volume of around 3%–5% of the bioreactor volume, was installed between the harvest pump from the reactor and the feed pump to the continuous capture process as illustrated s…”
BackgroundMethodInfluentialSelf-citationHigh-density mammalian cell cultures in stirred-tank bioreactor without external pH control
Xu, S., & Chen, H. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.06.019 · Cited by 99 · cited 1×
“Perfusion cultures provide stable operation at very high viable cell densities and viability which can produce proteins with increased purity.(4,11) In continuous multi-column capture processes, an increased capacity utilization, resulting in lower stationary phase and buffer consumption, can be obtained at high produ…”
Background
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Perfusion mammalian cell culture for recombinant protein manufacturing – A critical review
Bielser, J.-M., Wolf, M., Souquet, J., Broly, H., & Morbidelli, M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.04.011 · Cited by 263
Self-citationRecommendations for Comparison of Productivity Between Fed‐Batch and Perfusion Processes
Bausch, M., Schultheiss, C., & Sieck, J. B. (2019) · Biotechnology Journal · doi:10.1002/biot.201700721 · Cited by 73
Feidl, F., Garbellini, S., Vogg, S., Sokolov, M., Souquet, J., Broly, H., Butté, A., & Morbidelli, M. (2019) · Biotechnology Progress · doi:10.1002/btpr.2847 · Cited by 59
“It needs to be mentioned that for a successful industrial validation additional criteria like analytical specificity, robustness, and system suitability testing need to be considered.34 Nevertheless, this first successful showcase of using the Raman technology as an on-line monitoring device in DSP, opens up the oppor…”
MethodInfluentialSelf-citationContinuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
Rathore, A. S., Thakur, G., & Kateja, N. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28235 · Cited by 41
Metadata
- Authors
- Steinebach, F., Ulmer, N., Wolf, M., Decker, L., Schneider, V., Wälchli, R., Karst, D., Souquet, J., & Morbidelli, M.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2017-08-21
- Volume
- 33
- Issue
- 5
- Pages
- 1303-1313
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2735111094
- Cited by
- 128
- References
- 2
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.